Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dydrogesterone for threatened abortion in the first trimester
IRCT20120918010876N5Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dydrogesterone in threatened abortion (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Duration of vaginal bleeding and Occurrence of abortion. Started Nov 2017; status: completed.
02
Drugs
dydrogesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on IRCT20120918010876N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120918010876N5.